Adaptimmune Therapeutics (ADAP)
0.52
-0.02 (-3.70%)
At close: Mar 03, 2025, 3:59 PM
0.51
-2.46%
After-hours: Mar 03, 2025, 04:00 PM EST
Adaptimmune Therapeutics Revenue
Adaptimmune Therapeutics reported an annual revenue of $60.28M, reflecting a 122.05% growth. For the quarter ending September 30, 2024, Adaptimmune Therapeutics generated $40.9M in revenue.
Revenue (ttm)
$60.28M
Revenue Growth
122.05%
Price / Sales Ratio
15.87
Revenue / Employee
$134.26K
Employees
449
Market Cap
22.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 60.28M | +122.05% |
| Dec 31, 2022 | 27.15M | +341.50% |
| Dec 31, 2021 | 6.15M | +55.36% |
| Dec 31, 2020 | 3.96M | n/a |